临床流行病学核心概念:Meta分析中异质性的检测与处理
本文阐述Meta分析中研究间差异的成因与处理。异质性可通过森林图目视检查和I²、Q统计量检测,大I²或Q的小P值提示异质性,但大P值不排除异质性,报告I²的置信区间更有信息量。无异质性时用固定效应模型合并,存在实质性异质性时应探寻原因并考虑亚组分析、Meta回归或个体参与者数据,原因不明时用随机效应模型估计效应平均值,并结合预测区间指导决策。
要点
- 异质性检测用森林图目视检查联合I²与Q统计量,建议报告I²的置信区间。
- 无异质性用固定效应模型;存在实质性异质性应探寻原因,可做亚组分析或Meta回归。
- 原因不明的异质性用随机效应模型估计效应平均值,并参考预测区间指导决策。
核心结论
- 存在实质性异质性时不宜直接合并,应探寻原因;原因不明时随机效应模型估计的是所纳入研究人群效应范围的平均值而非单一真效应。
研究设计与样本
- 本文为临床流行病学方法学概念解读,阐述Meta分析中异质性的检测与处理,未报告具体研究样本。
主要发现
- 研究间效应估计的差异来源于真实差异(研究间变异)和机遇(研究内变异)。
- 大I²或Q统计量对应的小P值可能提示异质性,但大P值不代表无异质性。
- 报告I²的置信区间比单独报告I²点估计更有信息量。
关键数值与推荐
- 检测异质性采用两种互补方法:森林图目视检查和计算I²与Q等数值指标。
- 无异质性时用固定效应模型仅基于研究内变异合并真实效应估计。
- 存在实质性异质性时可采用亚组分析、Meta回归或个体参与者数据(IPD)分析。
- 原因不明的异质性采用随机效应模型,同时利用研究内和研究间变异合并估计。
- 随机效应合并估计需足够精确(置信区间窄),并结合预测区间指导临床与政策决策。
临床怎么用
- 临床决策前应评估Meta分析的异质性程度,避免在存在实质性异质性时直接使用单一合并估计。
- 对原因不明的异质性,随机效应合并估计应结合预测区间解读,以反映特定情境下效应的不确定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In a meta-analysis, a question always arises. Is it worthwhile to combine estimates from studies of different populations using various formulations of an intervention, evaluating outcomes measured differently? Sometimes even study designs differ. Differences are expected in a meta-analysis. These may be negligible, and a pooled estimate of effect can guide the clinical decision. However, when the differences are large, this estimate may mislead. Effect estimates from study to study differ because of real differences (between-study variability) and because of chance (within-study variability). To combine estimates when there is heterogeneity (between-study differences are large) may not be sensible. Two complementary methods may be used to detect heterogeneity: visual inspection of the forest plot and calculating numerical measures of heterogeneity (I2 and Q). Visual inspection can show effects that are different from the rest. A large I2 (proportion of overall variability attributed to between-study variation) or a small P-value associated with Q may suggest heterogeneity. Large P-values, however, do not mean the absence of heterogeneity. It is more informative to report the confidence interval of the I2. If there is no heterogeneity, a pooled estimate of the true effect may be generated using only within-study variation (fixed-effect model). If there is substantial heterogeneity, reasons should be sought. Subgroup analysis or meta-regression using study-level characteristics may be done. Although more involved and potentially challenging, individual-level data (Individual Participant Data, IPD) may also be used. In the case of unexplained heterogeneity, both within- and between-study variation should be used to generate a pooled estimate (random-effects model). This estimate does not estimate a single true effect but estimates the average of a range of effects of the intervention on populations represented by the studies. If precise enough (narrow confidence interval), this estimate, together with the prediction interval (a measure of uncertainty in the effect one might see in a particular context), can guide clinical and policy decisions.
引用
- Cordero CP, Dans AL. Key concepts in clinical epidemiology: detecting and dealing with heterogeneity in meta-analyses. J Clin Epidemiol. 2021. PMID: 33483004. doi:10.1016/j.jclinepi.2020.09.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。